Dr. Kevin Ray Campbell, MD

Dr. Campbell practices at Health First Medical Group in Rockledge, Florida.

Dr. Campbell's NPI, 1770581134, was assigned on July 11, 2005. Dr. Campbell graduated from Wake Forest School of Medicine in 1996. Dr. Campbell holds Florida license ME147231.

Dr. Campbell's primary practice is Health First Medical Group, at 3300 S Fiske Blvd, Rockledge, FL 32955 in Brevard County. The practice phone is (321) 434-5055.

Dr. Campbell's primary practice is Health First Medical Group in Rockledge, Florida. Dr. Campbell is also affiliated with Holmes Regional Medical Center. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Campbell to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Campbell practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Campbell's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Campbell is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Campbell's licenses on file in 4 states: Florida, North Carolina, New York and Virginia.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cerebrovascular disease, chronic hypertension, chronic skin ulcer, coronary artery disease, heart blockage and heart failure among the conditions Dr. Campbell treats.

CMS data shows 5,151 Medicare services from Dr. Campbell across 28 procedure codes in 2024, for 1,188 Medicare patients. Medicare paid $300,133 for them.

CMS counts 1,188 Medicare patients who saw Dr. Campbell in 2024. The largest group is 75 to 84, with 493 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Campbell's median patient age at 74, with 50% women.

In 2024, Dr. Campbell wrote 3,305 Medicare Part D claims for 558 patients. 89% of them were for generic drugs. CMS names the drug for 3,131 of them, across 34 drugs with 11 or more claims each, at $432,130 in total drug cost. In 2023, CMS named 2,291 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Campbell for performance year 2024, reported through an alternative payment model (APM). Dr. Campbell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 30 procedures of pacemaker insertion or repair by Dr. Campbell, more than 79% of the clinicians it reports for that procedure.

CMS Open Payments shows 246 general payments to Dr. Campbell from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Avertix Medical, Inc paid the most, $71,588.

Dr. Campbell graduated from Wake Forest School of Medicine in 1996. Dr. Campbell is a member of ACC.